Astera Labs (NASDAQ:ALAB) Shares Down 11.4% Following Insider Selling

Astera Labs, Inc. (NASDAQ:ALAB) shares fell 11.4% during trading on Friday after an insider sold shares in the company. The stock traded as low as $314.84 and last traded at $317.06. 7,269,806 shares changed hands during mid-day trading, an increase of 31% from the average session volume of 5,546,471 shares. The stock had previously closed at $358.05.

Specifically, Director Stefan A. Dyckerhoff sold 8,994 shares of the stock in a transaction that occurred on Wednesday, June 3rd. The stock was sold at an average price of $364.35, for a total value of $3,276,963.90. Following the completion of the sale, the director directly owned 5,292 shares of the company’s stock, valued at approximately $1,928,140.20. This represents a 62.96% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the firm’s stock in a transaction that occurred on Wednesday, June 3rd. The stock was sold at an average price of $364.35, for a total transaction of $1,277,046.75. Following the transaction, the director owned 60,134 shares in the company, valued at approximately $21,909,822.90. This trade represents a 5.51% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Analysts Set New Price Targets

A number of analysts recently weighed in on ALAB shares. Jefferies Financial Group reiterated a “buy” rating and set a $270.00 price target on shares of Astera Labs in a research note on Wednesday, May 6th. UBS Group began coverage on shares of Astera Labs in a report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 target price for the company. Barclays raised their price target on Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Stifel Nicolaus boosted their target price on Astera Labs from $236.00 to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Finally, Weiss Ratings raised Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Twelve research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $233.75.

Astera Labs Stock Down 11.4%

The business’s fifty day moving average is $212.95 and its 200 day moving average is $171.60. The stock has a market cap of $54.35 billion, a PE ratio of 214.23, a P/E/G ratio of 4.20 and a beta of 3.95.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. The company had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm’s quarterly revenue was up 93.5% compared to the same quarter last year. During the same period last year, the company posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, analysts predict that Astera Labs, Inc. will post 1.84 EPS for the current year.

Hedge Funds Weigh In On Astera Labs

Several hedge funds and other institutional investors have recently bought and sold shares of ALAB. Atreides Management LP grew its holdings in Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after purchasing an additional 1,754,593 shares during the last quarter. Vanguard Group Inc. raised its stake in shares of Astera Labs by 14.1% during the 3rd quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock worth $2,690,907,000 after buying an additional 1,693,918 shares during the last quarter. Amundi boosted its position in shares of Astera Labs by 1,298.6% in the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after buying an additional 1,319,643 shares in the last quarter. Rafferty Asset Management LLC purchased a new stake in shares of Astera Labs in the 3rd quarter worth about $209,599,000. Finally, BNP Paribas Financial Markets grew its stake in Astera Labs by 577.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock valued at $220,733,000 after acquiring an additional 960,899 shares during the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.